Jon C. Bates's Insider Trades & SAST Disclosures
Jon C. Bates's most recent trade in Nutex Health Inc was a trade of 3,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jon C. Bates.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,500 | 6,500 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,500 | 3,888 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 81.81 per share. | 01 Mar 2025 | 1,000 | 4,888 | - | 81.8 | 81,810 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 111 | 2,388 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 21.46 per share. | 22 Aug 2024 | 1,350 | 2,277 | - | 21.5 | 28,970 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 45,000 | 48,301 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 49,505 | 139,010 | - | - | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 49,505 | 49,505 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 15 Jun 2023 | 20,000 | 89,505 | - | 0.4 | 8,346 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 148,515 | 148,515 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 49,505 | 49,505 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 49,505 | 99,010 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 20,000 | 69,505 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 20,000 | 0 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 20,000 | 20,000 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges